CHU de Toulouse Hopital Larrey

Toulouse 31400

4 studies enrolling now · 6 studies all time

What they study most

BMM, Bone Marrow Mastocytosis, Cancer, Carcinoma, Non-Small-Cell Lung, ISM, Idiopathic Pulmonary Fibrosis, Mastocytosis, Mastocytosis, Indolent, Mastocytosis, Systemic, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer)

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• Met Non Small Cell Cancer Registry (MOMENT) — Recruiting now
• (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis — Running, not enrolling
• A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis — Running, not enrolling